Metabolic Brain Disease

Metabolic Brain Disease

ISSNs: 0885-7490

Additional searchable ISSN (Electronic): 1573-7365

Springer New York

Scopus rating (2018): CiteScore 2.53 SJR 0.795 SNIP 0.755

Journal

Journal Metrics

Research Output

  1. 2019
  2. Published

    The Rho kinase inhibitor fasudil attenuates Aβ1–42-induced apoptosis via the ASK1/JNK signal pathway in primary cultures of hippocampal neurons

    Gao, Y., Yan, Y., Fang, Q., Zhang, N., Kumar, G., Zhang, J., Song, L. & 4 others, Yu, J., Zhao, L., Zhang, H. & Ma, C., Dec 2019, In : Metabolic Brain Disease. 34, 6, p. 1787-1801

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journal

    Check@CityULib
  3. Published

    Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms

    Yan, Y., Yu, J., Gao, Y., Kumar, G., Guo, M., Zhao, Y., Fang, Q. & 5 others, Zhang, H., Yu, J., Jiang, Y., Zhang, H. & Ma, C., Apr 2019, In : Metabolic Brain Disease. 34, 2, p. 377-384

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journal

    Scopus citations: 1
    Check@CityULib
  4. 2015
  5. Astrocyte glycogen as an emergency fuel under conditions of glucose deprivation or intense neural activity

    Brown, A. M. & Ransom, B. R., Feb 2015, In : Metabolic Brain Disease. 30, 1, p. 233-239

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journal

    Scopus citations: 35
    Check@CityULib